139 related articles for article (PubMed ID: 7772515)
21. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders.
Sola B; Salaün V; Ballet JJ; Troussard X
Int J Cancer; 1999 Oct; 83(2):230-4. PubMed ID: 10471532
[TBL] [Abstract][Full Text] [Related]
22. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies.
Raynaud SD; Bekri S; Leroux D; Grosgeorge J; Klein B; Bastard C; Gaudray P; Simon MP
Genes Chromosomes Cancer; 1993 Oct; 8(2):80-7. PubMed ID: 7504521
[TBL] [Abstract][Full Text] [Related]
23. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
[TBL] [Abstract][Full Text] [Related]
24. Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.
de Boer CJ; Loyson S; Kluin PM; Kluin-Nelemans HC; Schuuring E; van Krieken JH
Cancer Res; 1993 Sep; 53(18):4148-52. PubMed ID: 8364907
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 overexpression in malignant lymphomas.
Nakamura S; Yatabe Y; Seto M
Pathol Int; 1997 Jul; 47(7):421-9. PubMed ID: 9234379
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
[TBL] [Abstract][Full Text] [Related]
28. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma.
de Boer CJ; Schuuring E; Dreef E; Peters G; Bartek J; Kluin PM; van Krieken JH
Blood; 1995 Oct; 86(7):2715-23. PubMed ID: 7670110
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32).
Shimazaki C; Goto H; Araki S; Tatsumi T; Takahashi R; Hirai H; Kikuta T; Yamagata N; Ashihara E; Inaba T; Fujita N; Suzuki R; Nakagawa M
Int J Hematol; 1997 Jul; 66(1):111-5. PubMed ID: 9220667
[TBL] [Abstract][Full Text] [Related]
31. The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene.
Vaandrager JW; Kluin P; Schuuring E
Blood; 1997 Jan; 89(1):349-50. PubMed ID: 8978314
[No Abstract] [Full Text] [Related]
32. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the CCND1 gene in hairy cell leukemia.
de Boer CJ; Kluin-Nelemans JC; Dreef E; Kester MG; Kluin PM; Schuuring E; van Krieken JH
Ann Oncol; 1996 Mar; 7(3):251-6. PubMed ID: 8740788
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent in situ hybridization analysis of an atypical t(11;14)(q13;q32) without expression of the cyclin D1 gene.
Raynaud SD; Gratecos N; Simon MP; Chischportich M; Grosgeorge J; Gaudray P; Ayraud N
Leukemia; 1993 Nov; 7(11):1924-7. PubMed ID: 8231265
[No Abstract] [Full Text] [Related]
35. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of cyclin D2 in chronic B-cell malignancies.
Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R
Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549
[TBL] [Abstract][Full Text] [Related]
37. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Krsková L; Soukup J; Campr V; Neskudla T; Szépe P; Plank L
Virchows Arch; 2003 Jun; 442(6):538-47. PubMed ID: 12728315
[TBL] [Abstract][Full Text] [Related]
38. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.
Williams ME; Swerdlow SH; Rosenberg CL; Arnold A
Cancer Res; 1992 Oct; 52(19 Suppl):5541s-5544s. PubMed ID: 1394169
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
Yang WI; Zukerberg LR; Motokura T; Arnold A; Harris NL
Am J Pathol; 1994 Jul; 145(1):86-96. PubMed ID: 7518196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
